Mini dialysis kit 1 kda

Manufactured by Merck Group

The Mini Dialysis Kit 1 kDa is a laboratory equipment used for dialysis. It facilitates the separation and concentration of molecules based on their molecular weight. The kit includes a dialysis membrane with a molecular weight cutoff of 1 kDa.

Automatically generated - may contain errors

Lab products found in correlation

Hydroxycinnamic acid, by Merck Group (2 mentions) Ruxolitinib, by Cayman Chemical (2 mentions) Perillyl alcohol, by Merck Group (2 mentions) Remdesivir, by Cayman Chemical (2 mentions) Ifn β, by Thermo Fisher Scientific (2 mentions) Cinnamic acid, by Merck Group (2 mentions) Human ifnα2, by PBL Assay Science (2 mentions) Dihydroxy cinammic acid caffeic acid, by Merck Group (2 mentions) Perilla aldehyde, by Merck Group (2 mentions) Amicon 100 k, by Merck Group (2 mentions)

2 protocols using mini dialysis kit 1 kda

Fractionation and Purification of Herbal Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols

Human IFNα2 was purchased from PBL Assay Science (#11101) and IFNβ from Peprotech (#300-02BC). Remdesivir and ruxolitinib were obtained from Cayman Chemicals (#30354) and Cell Guidance Systems (#SM87-10), respectively. The substances cinnamic acid, hydroxy-cinnamic acid, and dihydroxy-cinammic acid/caffeic acid were purchased from Sigma (#8002350250, #8002370050, #8220290010). Perilla aldehyde and perillyl alcohol were also obtained from Sigma (#W355704 and #218391). Size exclusion and protein fractionation of components of herbal infusions were conducted by use of Amicon 100 K, 30 K, 10 K, and 3 K filters (Sigma #UFC510024, #UFC501096, #UFC503096, #Z740183-96EA). The fraction of proteins > 1 kDa was obtained by dialysis using the Mini Dialysis Kit 1 kDa (Sigma #GE80-6483–94). All kits were applied according to the manufacturer’s instructions.

Le-Trilling V.T., Mennerich D., Schuler C., Sakson R., Lill J.K., Kasarla S.S., Kopczynski D., Loroch S., Flores-Martinez Y., Katschinski B., Wohlgemuth K., Gunzer M., Meyer F., Phapale P., Dittmer U., Sickmann A, & Trilling M. (2022). Identification of herbal teas and their compounds eliciting antiviral activity against SARS-CoV-2 in vitro. BMC Biology, 20, 264.

+ Open protocol

+ Expand

Fractionation and Purification of Herbal Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols

Human IFNα2 was purchased from PBL Assay Science (#11101) and IFNβ from Peprotech (#300-02BC). Remdesivir and ruxolitinib were obtained from Cayman Chemicals (#30354) and Cell Guidance Systems (#SM87-10), respectively. The substances cinnamic acid, hydroxy-cinnamic acid, and dihydroxy-cinammic acid/caffeic acid were purchased from Sigma (#8002350250, #8002370050, #8220290010). Perilla aldehyde and perillyl alcohol were also obtained from Sigma (#W355704 and #218391). Size exclusion and protein fractionation of components of herbal infusions were conducted by use of Amicon 100K, 30K, 10K, and 3K filters (Sigma #UFC510024, #UFC501096, #UFC503096, #Z740183-96EA). The fraction of proteins >1 kDa was obtained by dialysis using the Mini Dialysis Kit 1 kDa (Sigma #GE80-6483-94). All kits were applied according to the manufacturer´s instructions.

Le‐Trilling V.T.K., Mennerich D., Schuler C., Sakson R., Lill J.K., Kopczynski D., Loroch S., Flores-Martinez Y., Katschinski B., Wohlgemuth K., Gunzer M., Meyer F., Dittmer U., Sickmann A., & Trilling M. (2020). Universally available herbal teas based on sage and perilla elicit potent antiviral activity against SARS-CoV-2 variants of concern by HMOX-1 upregulation in human cells.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!